Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU214
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,977
Award facts
- Contract value 100% obligated
- $49,977.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $49,977.36 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors on November 26, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, demonstrates significant capability in fulfilling Department of Defense pharmaceutical needs through its extensive portfolio of competitively awarded delivery orders with the DLA. This specific award for Zepbound—a GLP-1 receptor agonist used for weight management—reflects the broader strategic approach by DLA Troop Support Medical to procure specialized medications across multiple therapeutic domains through its prime vendor network. The company's consistent track record of delivering diverse pharmaceutical products, from specialty medications to vaccines and medical devices, underscores its role as a vital component of the military healthcare supply chain and supports the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FU214?
SPE2DR26FU214 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FU214 worth?
The government has obligated $49,977 on SPE2DR26FU214.
Is contract SPE2DR26FU214 an order under another contract?
Yes. SPE2DR26FU214 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU214 competed?
The extent of competition for SPE2DR26FU214 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award